October 09, 2026 04:16 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Restriction, not complete closure’: Supreme Court questions Delhi shutdown ahead of CJP protest | 'Unwarranted': India hits back at JD Vance over ‘indentured servants’ remark amid US Green Card crackdown | US targets Microsoft, Infosys, Tata in green card crackdown | ‘Bold and inventive’: Canadian poet Anne Carson wins 2026 Nobel Prize in Literature | ‘Attempt to destabilise world’s largest democracy’: 42 retired judges rally behind Gyanesh Kumar over ‘vote chori’ row | ‘Vote chor, gaddi chod’: Dhruv Rathee, Prakash Raj join Bengaluru protest against Gyanesh Kumar | India condemns Houthi attacks on Saudi airports, calls targeting of civilian infrastructure unacceptable | Dalal Street bloodbath: Investors lose Rs. 8 lakh crore as Sensex crashes over 1,000 points | Amazon layoffs hit India, US and UK: Fresh job cuts rock e-commerce giant amid festive shopping season | Bollywood mourns Nana Patekar: Anupam Kher, Akshay Kumar, Jr NTR, Suniel Shetty pay emotional tributes
COVID19 Vaccine

US to possibly supply COVID-19 vaccine to other countries: Prez Donald Trump

| @indiablooms | Jul 29, 2020, at 05:52 pm

Washington/UNI:  US President Donald Trump during a press briefing said the United States may provide a vaccine for the novel coronavirus to other countries when it is ready.

"When we have that vaccine it will be discharged and taken care of," Trump told reporters on Tuesday. "It will be a very rapid process all over the country and perhaps we'll be supplying a lot of the vaccine to other parts of the world like we do with ventilators and other things that we all of a sudden have become very good at making."

The Trump administration aims to have a vaccine available by the end of the year or early 2021, says a Sputnik news report.

On Monday, the National Institutes of Health (NIH) said that US scientists have begun the phase three trial of the potential vaccine developed by the biotechnology company Moderna.

The NIH plans to conduct the trial at multiple US clinical research sites with participation of approximately 30,000 adult volunteers who are not infected with the novel coronavirus.

The United States has reported more than 4.3 million cases and more than 149,000 virus-related deaths as of Tuesday afternoon, according to data compiled by the Johns Hopkins University. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.